340B Covered Entity Report
Related Topics
340B Covered Entity Report
In 2023, the Minnesota Legislature enacted the Minnesota 340B Covered Entity Report (Minnesota Statutes 62J.461)— legislation focused on understanding the net financial impact of the federal 340B Drug Pricing Program on participating health care organizations in Minnesota. Minnesota was the first state to establish reporting and findings from this nation-leading initiative provide much needed transparency to the 340B program.
Health care organizations that participate in the federal 340B Drug Pricing Program—known as covered entities—are required to annually report data related to their 340B prescription drug purchases and payments to the Minnesota Department of Health (MDH). MDH submits its findings to the Minnesota Legislature in annual reports each November.
For news and notifications, sign up for email updates.
Reporting Resources
Minnesota covered entities are required to report and certify 340B data annually. The 340B Covered Entity Report Reporting Resources page includes all the information covered entities need to submit data to MDH.
Publications
Reporting from 340B covered entities is reviewed and published in an annual report to the Minnesota Legislature. These reports along with other publications are available on the 340B Covered Entity Report Publications page.